Clinical and Lab Diagnostics - Broad-spectrum neutralizing antibody: Effectively Neutralize Dominant SARS-CoV-2 Variants
Can't see this email? View it online
   
  Clinical and Lab Diagnostics  
  The latest clinical and lab diagnostics news from News Medical  
 

Are Serological Tests Unreliable? Or the Protein Reagents?Interrogate COVID-19 and get more answers

Tecan’s SARS-CoV-2 toolkit is a comprehensive set of high-quality reagents that enables you to get deeper insights from your viral samples. Gain unparalleled insight into COVID-19 using a combination of methods, including reliable serological ELISA testing of HMGB1, neopterin or SARS-CoV-2 S1/RBD IgG antibody to assess immunity and etiology of immune response to coronavirus.

View Tecan's COVID-19 Portfolio
 
 
    Keysight Broad-spectrum neutralizing antibody: Effectively Neutralize Dominant SARS-CoV-2 Variants
 
It is exciting that an anti-SARS-CoV-2 Spike RBD neutralizing antibody (Cat. No. S1N-M122), developed by ACROBiosystems, retains potent neutralizing activity against dominant SARS-CoV-2 variants as tested by pseudovirus assay. The broad-spectrum neutralizing antibody is suitable to be a positive control in neutralization antibody screening, QC test reagent for both recombinant protein vaccines, and COVID-19 neutralizing antibody detection in vaccinated serum.
 
Find Out More
 
 
   Novel, non-invasive biomarker test could help measure, track performance of senolyticsNovel, non-invasive biomarker test could help measure, track performance of senolytics
 
Scientists from Buck Institute have identified and are now developing an innovative, non-invasive biomarker test that could help quantify and track the performance of senolytics—a class of drugs that selectively destroy senescent cells.
 
 New biomarker of glucocorticoid action could help clinicians to tailor treatments
 
New biomarker of glucocorticoid action could help clinicians to tailor treatmentsResearchers have uncovered pathways involved in the body's response to glucocorticoid treatments and identified a novel biomarker that could be used to monitor how these drugs work in patients, according to a clinical study published today in eLife.
 
 
 Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseases
 
Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseasesExcessive fat accumulation in the liver can lead to serious medical problems, including liver failure. Thus, understanding the distribution of lipids within the liver is a critical step in diagnosing fatty liver diseases.
 
 
 New sweat stickers may streamline diagnosis, treatment of cystic fibrosis in in pediatric patients
 
New sweat stickers may streamline diagnosis, treatment of cystic fibrosis in in pediatric patientsNew "sweat stickers" may streamline the early diagnosis of cystic fibrosis by enabling scientists to easily gather and analyze sweat from the skin of infants and children.
 
 
 New label-free immune profiling assay to assess rapidly changing host immune response
 
New label-free immune profiling assay to assess rapidly changing host immune responseResearchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have developed a new label-free immune profiling assay that profiles the rapidly changing host immune response in case of infection, in a departure from existing methods that focus on detecting the pathogens...